Table 4.
Lg10 Inflammatory Responses following a HFM
| EX | CON | Group effect | Time effect | Group x time | |
|---|---|---|---|---|---|
| hs-CRP (Lg10) | |||||
| Baseline | 0.61 ± 0.69 | 0.69 ± 0.83 | |||
| 2 h | |||||
| 4 h | |||||
| IL-1β (Lg10) | p = 0.687 | ||||
| Baseline | 0.47 ± 0.19 | 0.44 ± 0.28 | p = 0.727 | ||
| 2 h | 0.39 ± 0.25a | 0.35 ± 0.29a | |||
| 4 h | 0.35 ± 0.22a | 0.32 ± 0.38 | p = 0.007b | ||
| IL-6 (Lg10) | p = 0.276 | ||||
| Baseline | −0.17 ± 0.24 | −0.16 ± 0.26 | p = 0.184 | ||
| 2 h | −0.39 ± 0.33a | −0.18 ± 0.28 | |||
| 4 h | −0.11 ± 0.33 | −0.06 ± 0.40 | p = 0.012b | ||
| dIL-8 (pg/ml) | p = 0.712 | ||||
| Baseline | 5.72 ± 1.27 | 4.90 ± 1.44 | p = 0.311 | ||
| 2 h | 4.27 ± 1.88a | 4.52 ± 1.58 | |||
| 4 h | 4.27 ± 2.08a | 4.40 ± 1.86 | p = 0.036b | ||
| IL-10 (Lg10) | p = 0.298 | ||||
| Baseline | 0.64 ± 0.22 | 0.62 ± 0.27 | p = 0.212 | ||
| 2 h | 0.45 ± 0.35a | 0.56 ± 0.28 | |||
| 4 h | 0.46 ± 0.29a | 0.62 ± 0.35 | p = 0.094 | ||
| dTNF-α (pg/ml) | p = 0.310 | ||||
| Baseline | 4.79 ± 1.93 | 5.72 ± 1.89 | p = 0.838 | ||
| 2 h | 3.75 ± 2.66 | 4.68 ± 2.36a | |||
| 4 h | 3.86 ± 2.02 | 4.37 ± 2.69a | p = 0.013b | ||
| sICAM-1 (Lg10) | p = 0.746 | ||||
| Baseline | 1.89 ± 0.11 | 1.87 ± 0.10 | p = 0.958 | ||
| 4 h | 1.87 ± 0.15 | 1.86 ± 0.10 | p = 0.370 | ||
| dsVCAM-1 (ng/ml) | p = 0.819 | ||||
| Baseline | 585.42 ± 125.58 | 599.30 ± 150.11 | p = 0.020c | ||
| 4 h | 632.76 ± 134.96a | 598.14 ± 141.08 | p = 0.027b |
aIndicates a significant pairwise change from baseline
bIndicates a significant main effect
cIndicates a significant group x time interaction
dIndicates raw data that met parametric assumptions and did not require Lg10 transformation
hs-CRP was only measured at baseline, sICAM-1 and sVCAM-1 were only measured at baseline and 4 h. All data are presented as mean ± SD. Significance set at (p < 0.05)